Last Price$155.9(0.3%)
Market Cap$19.3B
(2.0%)
Peers median - 2.3%
9.7%
Peers median - 12.8%
2,555.4%
Peers median - 78.8%
38.2%
Peers median - 17.2%
Competing with CLX
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$19.3B | 6.6 | $117.2 24.8% overvalued | 5.0% | $7,165.0M | $695.0M | (2.0%) | 9.7% | 44.5% | 38.2% | 2,555.4% | |
$411.8B | 7.1 | $135.9 22.6% overvalued | 12.1% | $84.3B | $16.7B | 0.5% | 19.8% | 51.3% | 19.2% | 67.4% | |
$143.6B | 7.0 | $90.7 57.2% undervalued | 20.3% | €120.4B | €15.8B | 7.0% | 13.1% | 71.4% | 31.3% | 142.1% | |
$75.3B | 7.0 | $83.3 10.2% overvalued | 8.6% | $20.1B | $3,546.0M | 3.3% | 17.6% | 60.5% | 30.9% | 1,564.7% | |
$47.9B | 6.4 | $160.0 11.6% undervalued | 20.3% | $20.1B | $2,513.0M | (1.8%) | 12.5% | 35.8% | 28.9% | 705.1% | |
$45.5B | 5.8 | $21.1 11.3% overvalued | 29.2% | $15.5B | $1,335.0M | 0.1% | 8.6% | 57.9% | 10.1% | 90.2% | |
$27.1B | 6.3 | $79.8 28.8% overvalued | 11.9% | $6,107.1M | $976.4M | 4.1% | 16.0% | 45.2% | 8.9% | 41.1% | |
$25.7B | 5.0 | $93.6 33.4% undervalued | (51.7%) | $15.2B | $1,145.0M | 0.1% | 7.6% | 73.1% | 0.2% | 225.1% | |
$9,261.6M | 7.3 | $22.2 45.4% overvalued | 176.7% | $1,476.5M | $198.3M | 69.3% | 13.4% | 76.6% | 55.5% | 2.4% | |
$4,901.6M | 5.1 | $15.4 182.3% undervalued | (56.1%) | $6,090.4M | $293.5M | 1.3% | 4.8% | 64.6% | 7.0% | 7.8% | |
$3,814.9M | 6.1 | $64.1 0.4% undervalued | (69.5%) | $1,302.0M | $24.6M | 46.3% | 1.9% | 71.1% | 15.2% | 39.4% |
Compare CLX Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
The Clorox CompanyCLX
3.1x
(4.0%)
86.0%
3.9%
Median Peer Set
3.3x
2.9%
(17.5%)
10.2%
Church & Dwight Co., Inc.CHD
4.6x
4.1%
(22.7%)
9.6%
Colgate-Palmolive CompanyCL
4.1x
3.3%
27.0%
14.4%
Coty Inc.COTY
0.8x
10.2%
(85.0%)
1.5%
The Estée Lauder Companies Inc.EL
2.1x
(1.9%)
(61.2%)
2.5%
e.l.f. Beauty, Inc.ELF
3.1x
76.9%
99.1%
12.5%
Hims & Hers Health, Inc.HIMS
6.1x
65.5%
(65.6%)
(2.7%)
Kimberly-Clark CorporationKMB
2.7x
(1.8%)
45.5%
12.7%
Kenvue Inc.KVUE
3.4x
0.1%
(40.0%)
6.7%
The Procter & Gamble CompanyPG
5.2x
2.5%
3.8%
17.7%
Unilever PLCUL
1.3x
1.8%
(12.4%)
10.9%
Compare CLX Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does The Clorox Company (CLX) revenue growth compare to peers and the industry?
The Clorox Company (CLX) revenue growth is (2.0%), compared to the peers' median of 2.3%.
2. How does The Clorox Company (CLX) Free Cash Flow (FCF) margin compare to peers and the industry?
The Clorox Company (CLX) FCF margin is 9.7%, compared to the peers' median of 12.8%.
3. How does The Clorox Company (CLX) Total Debt to Equity ratio compare to peers and the industry?
The Clorox Company (CLX) Total Debt to Equity ratio is 2,555.4%, compared to the peers' median of 78.8%.
4. How does The Clorox Company (CLX) ROIC (Return on Invested Capital) compare to peers and the industry?
The Clorox Company (CLX) ROIC is 38.2%, compared to the peers' median of 17.2%.